Date Filed | Type | Description |
07/05/2023 |
4
| GRINT PAUL C (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.
Txns:
| Granted 6,667 options to buy
@ $3.61, valued at
$24.1k
|
|
06/28/2022 |
4
| GRINT PAUL C (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.
Txns:
| Granted 40,000 options to buy
@ $0.81, valued at
$32.4k
|
|
06/29/2021 |
4
| GRINT PAUL C (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.
Txns:
| Granted 22,677 options to buy
@ $2.92, valued at
$66.2k
|
|
12/29/2020 |
4
| GRINT PAUL C (Director) has filed a Form 4 on Inhibikase Therapeutics, Inc.
Txns:
| Granted 6,825 options to buy
@ $10, valued at
$68.3k
|
|
12/22/2020 |
3
| GRINT PAUL C (Director) has filed a Form 3 on Inhibikase Therapeutics, Inc. |
12/12/2017 |
4
| GRINT PAUL C (CEO) has filed a Form 4 on AmpliPhi Biosciences Corp
Txns:
| Granted 599 shares
@ $0.62, valued at
$371.4 |
|
09/11/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/23/2017 |
4
| GRINT PAUL C (President & CEO) has filed a Form 4 on Regulus Therapeutics Inc. |
02/01/2017 |
4
| GRINT PAUL C (President & CEO) has filed a Form 4 on Regulus Therapeutics Inc. |
10/07/2016 |
4
| GRINT PAUL C (President & CEO) has filed a Form 4 on Regulus Therapeutics Inc. |
02/05/2016 |
4
| GRINT PAUL C (President & CEO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 265,000 options to buy
@ $6.35, valued at
$1.7M
|
|
01/06/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/09/2015 |
4
| GRINT PAUL C (Director) has filed a Form 4 on AmpliPhi Biosciences Corp
Txns:
| Granted 16,200 options to buy
@ $5.65, valued at
$91.5k
|
|
06/26/2015 |
4
| GRINT PAUL C (President & CEO) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 500,000 options to buy
@ $10.22, valued at
$5.1M
|
|
12/04/2014 |
4
| GRINT PAUL C (Chief Medical Officer) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 50,870 options to buy
@ $17.76, valued at
$903.5k
|
|
10/22/2014 |
4
| GRINT PAUL C (Chief Medical Officer) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 40,000 options to buy
@ $7.58, valued at
$303.2k
|
|
06/18/2014 |
4
| GRINT PAUL C (Chief Medical Officer) has filed a Form 4 on Regulus Therapeutics Inc.
Txns:
| Granted 250,000 options to buy
@ $7.58, valued at
$1.9M
|
|
01/07/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/03/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/05/2012 |
4
| GRINT PAUL C (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Granted 333 shares
@ $44.95, valued at
$15k
|
|
04/20/2012 |
4
| GRINT PAUL C (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Granted 1,440 shares
@ $0 Granted 10,800 options to buy
@ $44.51, valued at
$480.7k
|
|
04/09/2012 |
4
| GRINT PAUL C (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Granted 314 shares
@ $0 |
|
05/12/2011 |
4
| GRINT PAUL C (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Granted 1,440 shares
@ $0 Granted 10,800 options to buy
@ $75.66, valued at
$817.1k
|
|
10/29/2010 |
4
| GRINT PAUL C (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Sold 1,900 shares
@ $54.9853, valued at
$104.5k
Sold 8,100 shares
@ $56.0027, valued at
$453.6k
Exercised 10,000 options to buy
@ $4.355, valued at
$43.6k
|
|
10/29/2010 |
4
| GRINT PAUL C (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Sold 10,000 shares
@ $47.0038, valued at
$470k
Exercised 10,000 options to buy
@ $4.355, valued at
$43.6k
|
|
08/03/2010 |
4
| GRINT PAUL C (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Sold 10,000 shares
@ $43.473, valued at
$434.7k
Exercised 10,000 options to buy
@ $4.355, valued at
$43.6k
|
|
05/12/2010 |
4
| GRINT PAUL C (Director) has filed a Form 4 on ILLUMINA INC
Txns:
| Disposed/sold 800 shares
@ $41.89, valued at
$33.5k
Granted 1,800 shares
@ $0 Granted 13,500 options to buy
@ $42.82, valued at
$578.1k
|
|
05/11/2009 |
4
| GRINT PAUL C (Director) has filed a Form 4 on ILLUMINA INC |